Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,009 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Intermittent administration of a sustained-release prostacyclin analog ONO-1301 ameliorates renal alterations in a rat type 1 diabetes model.
Yamasaki H, Maeshima Y, Nasu T, Saito D, Tanabe K, Hirokoshi-Kawahara K, Sugiyama H, Sakai Y, Makino H. Yamasaki H, et al. Among authors: tanabe k. Prostaglandins Leukot Essent Fatty Acids. 2011 Mar-Apr;84(3-4):99-107. doi: 10.1016/j.plefa.2010.11.005. Epub 2010 Dec 21. Prostaglandins Leukot Essent Fatty Acids. 2011. PMID: 21177088
Amelioration of renal alterations in obese type 2 diabetic mice by vasohibin-1, a negative feedback regulator of angiogenesis.
Saito D, Maeshima Y, Nasu T, Yamasaki H, Tanabe K, Sugiyama H, Sonoda H, Sato Y, Makino H. Saito D, et al. Among authors: tanabe k. Am J Physiol Renal Physiol. 2011 Apr;300(4):F873-86. doi: 10.1152/ajprenal.00503.2010. Epub 2011 Jan 12. Am J Physiol Renal Physiol. 2011. PMID: 21228103 Free article.
We recently reported the therapeutic effects of vasohibin-1 (VASH-1), an endogenous angiogenesis inhibitor, in a type 1 diabetic nephropathy model (Nasu T, Maeshima Y, Kinomura M, Hirokoshi-Kawahara K, Tanabe K, Sugiyama H, Sonoda H, Sato Y, Makino H. Diabete …
We recently reported the therapeutic effects of vasohibin-1 (VASH-1), an endogenous angiogenesis inhibitor, in a type 1 diabetic nephropathy …
Sustained-release prostacyclin analog ONO-1301 ameliorates tubulointerstitial alterations in a mouse obstructive nephropathy model.
Nasu T, Kinomura M, Tanabe K, Yamasaki H, Htay SL, Saito D, Hinamoto N, Watatani H, Ujike H, Suzuki Y, Sugaya T, Sugiyama H, Sakai Y, Matsumoto K, Maeshima Y, Makino H. Nasu T, et al. Among authors: tanabe k. Am J Physiol Renal Physiol. 2012 Jun 15;302(12):F1616-29. doi: 10.1152/ajprenal.00538.2011. Epub 2012 Mar 14. Am J Physiol Renal Physiol. 2012. PMID: 22419696 Free article.
Epicatechin limits renal injury by mitochondrial protection in cisplatin nephropathy.
Tanabe K, Tamura Y, Lanaspa MA, Miyazaki M, Suzuki N, Sato W, Maeshima Y, Schreiner GF, Villarreal FJ, Johnson RJ, Nakagawa T. Tanabe K, et al. Am J Physiol Renal Physiol. 2012 Nov 1;303(9):F1264-74. doi: 10.1152/ajprenal.00227.2012. Epub 2012 Aug 29. Am J Physiol Renal Physiol. 2012. PMID: 22933302 Free PMC article.
3,009 results